Navigating the Cancer Maze

Attending the American Association for Cancer Research annual meeting is always a rejuvenating—yet exhausting—experience. First, you get to go to some nice places: New Orleans, San Francisco (twice in three years), even Philadelphia one year. But it's not the places where these meetings are held, but the research you hear about that is simply overwhelming when compressed into a five-day time frame. In this issue, our cancer research focus for this year, we discuss some of the themes

Written byLarry Hand

| 2 min read

Save for Later

Listen with Speechify

0:00

2:00

In this issue, our cancer research focus for this year, we discuss some of the themes that emanated from the AACR meeting held in early April in San Francisco. Starting with our cover story, "Reining in a Killer Disease," by Christine Bahls and Mignon Fogarty, researchers explain why efforts to treat cancer as a chronic disease can benefit more people than just focusing on finding a cure for the many types of cancer. No one is losing sight of that goal, a cure, but investigators are looking into disease management as a way to buy time for cancer patients.

Another theme—something that we constantly cover and will continue to do so—that surfaced at the meeting is that the technology available in labs today has great potential to accelerate cancer research and to individualize cancer treatment. Some of the most promising emerging technologies are in proteomics.

In one presentation, Bin Ye, ...

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!

Join for free today

Already a member? Login Here